Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PASK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
THAP10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Q2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MALT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AURKA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRFAP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIP13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLSCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF2BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM210A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC17A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on